论文部分内容阅读
检测128例不同肝病患者血清中GSTs活性，以探讨其对肝病的诊断价值。不同肝病患者血清GSTs活性依次为：AH组＞CAH组＞CPH组＞LC组，与正常对照组比较均有显著性差异（P＜0．01）。肝癌组患者血清GSTs活性与正常对照组没有显著性差异（P＞0．05）。结果提示：1．GSTs活性可能与肝细胞的通透性增大及肝细胞坏死程度有关。2．肝癌时，肝脏所合成的GST的类型可能发生了改变。
The serum GSTs activity of 128 patients with different liver diseases was detected to explore its diagnostic value of liver disease. The serum GSTs activities of patients with different liver diseases were as follows: AH group> CAH group> CPH group> LC group, there was significant difference compared with the normal control group (P <0.01). There was no significant difference in serum GSTs activity between HCC patients and normal controls (P> 0.05). The results suggest: 1. GSTs activity may be related to the increased permeability of hepatocytes and the degree of hepatocyte necrosis. 2. Liver cancer, liver synthesis of GST types may have changed.